Načítá se...
Systemic delivery of adeno-associated viral vectors
For diseases like muscular dystrophy, an effective gene therapy requires bodywide correction. Systemic viral vector delivery has been attempted since early 90s. Yet a true success was not achieved until mid-2000 when adeno-associated virus (AAV) serotype-6, 8 and 9 were found to result in global mus...
Uloženo v:
| Médium: | Článek |
|---|---|
| Jazyk: | en |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5138077/ https://ncbi.nlm.nih.gov/pubmed/27459604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coviro.2016.07.006 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|